Young, healthy soldiers (aged 18-20 years) were referred to the Sheba Medical Center for evaluation of recurrent syncope. Participants were recruited to the study between July 2002 and July 2004.

Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial.

The modern debate over ICSs in COPD has the catnip required to produce an academic catfight. It pits "statements" against ...

Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...

Healthcare providers should adopt preventive measures for both asthma and type 2 diabetes in patients diagnosed with either ...

Some argue universal suicide screening saves lives. Others contend it is ineffective and possibly harmful. So, what is the most effective way to prevent suicide?

Medscape spoke with Professor Zhenyue Chen of Shanghai Jiao Tong University of Medicine in China about her research into the ...

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

A new analysis sheds light on the unique challenges faced by FG medical students and the type of support they need from their ...

Nearly 22% of people who died of drug overdose in 2022 had a non-substance–related mental illness, underscoring the need for ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

Air pollution was associated with a higher risk for infertility in men, whereas road traffic noise was associated with a higher risk for infertility in women, a new study found.